Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5278417
Max Phase: Preclinical
Molecular Formula: C51H54BF2N5O3S
Molecular Weight: 865.90
Associated Items:
ID: ALA5278417
Max Phase: Preclinical
Molecular Formula: C51H54BF2N5O3S
Molecular Weight: 865.90
Associated Items:
Canonical SMILES: O=C(COc1ccc(-c2ccc3n2[B-](F)(F)[N+]2=C(c4cccs4)C=CC2=C3)cc1)NCCCCCCn1cc(CCCCN2CCC3(CC2)OCc2ccccc23)c2ccccc21
Standard InChI: InChI=1S/C51H54BF2N5O3S/c53-52(54)58-41(34-42-21-25-48(59(42)52)49-17-11-33-63-49)20-24-46(58)38-18-22-43(23-19-38)61-37-50(60)55-28-8-1-2-9-30-57-35-39(44-14-4-6-16-47(44)57)12-7-10-29-56-31-26-51(27-32-56)45-15-5-3-13-40(45)36-62-51/h3-6,11,13-25,33-35H,1-2,7-10,12,26-32,36-37H2,(H,55,60)
Standard InChI Key: IKSSSOWOJYECQR-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 865.90 | Molecular Weight (Monoisotopic): 865.4008 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Abatematteo FS, Majellaro M, Montsch B, Prieto-Díaz R, Niso M, Contino M, Stefanachi A, Riganti C, Mangiatordi GF, Delre P, Heffeter P, Sotelo E, Abate C.. (2023) Development of Fluorescent 4-[4-(3H-Spiro[isobenzofuran-1,4'-piperidin]-1'-yl)butyl]indolyl Derivatives as High-Affinity Probes to Enable the Study of σ Receptors via Fluorescence-Based Techniques., 66 (6): [PMID:36919956] [10.1021/acs.jmedchem.2c01227] |
Source(1):